Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial

Autor: Jespersen, Christian M, Kolmos, H J, Frydendall, N, Hilden, Jørgen, Gluud, C, Hansen, Jørgen Fischer, Trial Group, CLARICOR

Publikováno v: Jespersen, C M, Kolmos, H J, Frydendall, N, Hilden, J, Gluud, C, Hansen, J F & Trial Group, CLARICOR 2009, ' Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial ', Journal of Antimicrobial Chemotherapy, vol. 64, no. 2, pp. 411-5 . https://doi.org/10.1093/jac/dkp190

Udgivelsesdato: 2009-Aug BACKGROUND: The randomized placebo-controlled double-blind CLARICOR trial investigated the influence of clarithromycin versus placebo on cardiovascular events and mortality in patients with chronic coronary artery disease (Cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e76e5c5ccc962e5907a60a95f6ef182
https://portal.findresearcher.sdu.dk/da/publications/7c020d70-7c2f-11de-9c46-000ea68e967b